Recreating the Natural Wound Healing Environment
ActiGraft, based on RedDress’ proprietary patented technology, is a FDA-cleared wound care solution that enables health care providers to produce—in real time—in vitro blood clot tissue from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering and supports wound healing processes which naturally occur in the patient's body.
Can be easily prepared at the patient’s bedside in 12 minutes
Provides significant savings in nursing costs and simplifies wound treatment
Fast healing with less wound interaction
Seamlessly integrates into current chronic wound treatment practices
Enables front line staff to easily execute ongoing wound treatment
Uses the patient’s own blood to support the body’s own healing processes
Standard of Care topical dressings address one or two aspects of a chronic wound bed. The ActiGraft dressing contains the fibrin matrix (derived from the patient's own blood) acting to support the body's own wound healing processes.
ActiGraft changes the way we treat chronic wounds by supporting every stage of the wound healing process and taking the guesswork out of wound treatment.
ActiGraft is contraindicated in patients with the following types of wounds:
ActiGraft® Virtual Training is a quick and easy program designed to fit your busy schedule. Begin treating patients immediately within your health care setting.